相似文献
1
Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4235-9. doi: 10.1073/pnas.82.12.4235.
2
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
Proc Natl Acad Sci U S A. 1984 Feb;81(3):881-5. doi: 10.1073/pnas.81.3.881.
3
Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
Eur J Immunol. 1991 Nov;21(11):2829-38. doi: 10.1002/eji.1830211126.
4
Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
J Biol Chem. 1990 Jul 25;265(21):12293-9.
5
Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
J Immunol. 2001 Nov 15;167(10):5758-66. doi: 10.4049/jimmunol.167.10.5758.
6
Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.
Biochem J. 1990 May 15;268(1):55-61. doi: 10.1042/bj2680055.
7
Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
J Exp Med. 1983 Aug 1;158(2):334-52. doi: 10.1084/jem.158.2.334.
8
Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
EMBO J. 1991 Apr;10(4):919-26. doi: 10.1002/j.1460-2075.1991.tb08025.x.
9
Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
Immunology. 1988 Oct;65(2):237-41.
10
Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).
J Immunol. 2000 Oct 1;165(7):3839-48. doi: 10.4049/jimmunol.165.7.3839.
引用本文的文献
1
C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells.
Immunol Cell Biol. 2015 Feb;93(2):189-97. doi: 10.1038/icb.2014.89. Epub 2014 Nov 11.
2
A new DNA vaccine fused with the C3d-p28 induces a Th2 immune response against amyloid-beta.
Neural Regen Res. 2013 Sep 25;8(27):2581-90. doi: 10.3969/j.issn.1673-5374.2013.27.010.
3
Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.
Adv Exp Med Biol. 2012;946:113-33. doi: 10.1007/978-1-4614-0106-3_7.
4
Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus.
Virol J. 2010 May 9;7:89. doi: 10.1186/1743-422X-7-89.
5
Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.
Antiviral Res. 2008 Jul;79(1):6-11. doi: 10.1016/j.antiviral.2008.01.160. Epub 2008 Mar 31.
6
Epstein-Barr virus entry.
J Virol. 2007 Aug;81(15):7825-32. doi: 10.1128/JVI.00445-07. Epub 2007 Apr 25.
7
Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.
Immunol Res. 2006;36(1-3):197-210. doi: 10.1385/IR:36:1:197.
8
Contribution of C3d-P28 repeats to enhancement of immune responses against HBV-preS2/S induced by gene immunization.
World J Gastroenterol. 2004 Jul 15;10(14):2072-7. doi: 10.3748/wjg.v10.i14.2072.
9
Viral mimicry of the complement system.
J Biosci. 2003 Apr;28(3):249-64. doi: 10.1007/BF02970145.
10
Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trapping.
Immunol Res. 1999;20(3):187-94. doi: 10.1007/BF02790402.
本文引用的文献
1
A simple method for displaying the hydropathic character of a protein.
J Mol Biol. 1982 May 5;157(1):105-32. doi: 10.1016/0022-2836(82)90515-0.
2
Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
J Immunol. 1982 Jan;128(1):186-9.
3
The proteolytic activation systems of complement.
Annu Rev Biochem. 1981;50:433-64. doi: 10.1146/annurev.bi.50.070181.002245.
4
Selective inhibition of functional sites of cell-bound C3b by hybridoma-derived antibodies.
J Immunol. 1982 Jan;128(1):512-4.
5
Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
J Immunol. 1984 Apr;132(4):1960-6.
6
7
C3d receptors are expressed on human monocytes after in vitro cultivation.
Proc Natl Acad Sci U S A. 1983 Apr;80(8):2351-5. doi: 10.1073/pnas.80.8.2351.
8
Structure and function of the anaphylatoxins.
Springer Semin Immunopathol. 1984;7(2-3):193-219. doi: 10.1007/BF01893020.
9
Regulation of immune response by components of the complement cascade and their activated fragments.
Springer Semin Immunopathol. 1983;6(2-3):173-94. doi: 10.1007/BF00205872.
10
C3d-K, a kallikrein cleavage fragment of iC3b is a potent inhibitor of cellular proliferation.
J Immunol. 1984 Nov;133(5):2629-33.
Zotero 插件